Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Clinical trial NCT02793583 · TERMINATED
Trial details
- NCT number
- NCT02793583
- Sponsor
- TG Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-25
- Primary completion
- 2022-05-31
- Enrollment
- 710
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.